Macular blood flow changes in dysthyroid optic neuropathy after high-dose intravenous pulse methylprednisolone (IVMP)

被引:1
|
作者
Fan, Shu-xian [1 ]
Liang, Jia-qi [1 ]
Wang, Jing [1 ]
Zhou, Chong [1 ]
Zhou, Shi-you [2 ]
Wang, Mei [1 ]
Zeng, Peng [1 ]
机构
[1] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Ophthalmol, 107 West Yanjiang Rd, Guangzhou 510120, Peoples R China
[2] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, 54 South Xianlie Rd, Guangzhou 510060, Peoples R China
关键词
Dysthyroid optic neuropathy; Methylprednisolone; Macula; Vessel densities; Optical coherence tomography angiography; GRAVES ORBITOPATHY EUGOGO; EUROPEAN GROUP; MANAGEMENT; GUIDELINES; PERFUSION; DENSITY;
D O I
10.1016/j.pdpdt.2023.103935
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To investigate the changes in macular vessel density (VD) of the superficial layer of retina (SLR) and deep layer of retina (DLR) in dysthyroid optic neuropathy (DON) after high-dose intravenous pulse methyl-prednisolone (IVMP). Materials and Methods: Eighteen DON patients (29 eyes) who completed high-dose IVMP and 16 healthy in-dividuals (32 eyes) were enrolled in this study. Optical coherence tomography angiography (OCTA) image analysis and comprehensive ophthalmic examinations were performed, including the SLR macular whole-image VD (SLR-mwiVD) and DLR-mwiVD, best-corrected visual acuity (BCVA), the mean deviation of visual field (VF-MD), pattern standard deviation of visual field (VF-PSD) and the other parameters.Results: The SLR-mwiVD (41.39 +/- 4.71 vs. 48.13 +/- 3.68, p < 0.001) and DLR-mwiVD (40.77 +/- 5.85 vs. 49.14 +/- 7.02, p < 0.001) were decreased in DON compared to control eyes. After IVMP, visual function parameters were improved, and SLR-mwiVD (49.41 +/- 3.18, p < 0.001) and DLR-mwiVD (50.41 +/- 4.04, p < 0.001) were increased in the DON group compared to pretreatment. The increased SLR-mwiVD and DLR-mwiVD were significantly correlated with improvements in BCVA (Log MAR: from 0.62 +/- 0.49 to-0.01 +/- 0.03, p < 0.001), VF-MD (from - 6.89 +/- 2.89 dB to - 1.75 +/- 1.29 dB, p < 0.001) and VF-PSD (from 4.38 +/- 2.52 dB to 2.32 +/- 1.64 dB, p < 0.001).Conclusion: The increase in macular VD was significantly correlated with the improvement in visual function in DON after IVMP. Macular VD changes on OCTA may be a useful indicator for the response in DON after IVMP.
引用
收藏
页数:6
相关论文
共 21 条
  • [1] Therapeutic Outcomes of High-Dose Intravenous Steroids in the Treatment of Dysthyroid Optic Neuropathy
    Curro, Nicola
    Covelli, Danila
    Vannucchi, Guia
    Campi, Irene
    Pirola, Giacinta
    Simonetta, Simona
    Dazzi, Davide
    Guastella, Claudio
    Pignataro, Lorenzo
    Beck-Peccoz, Paolo
    Ratiglia, Roberto
    Salvi, Mario
    THYROID, 2014, 24 (05) : 897 - 905
  • [2] Dysthyroid Optic Neuropathy: Treatment with Additional Intravenous Methylprednisolone Pulses after the Basic Schedule Is Associated with Stabilization or Further Improvement of Clinical Outcome
    Pelewicz, Maryla
    Rymuza, Joanna
    Pelewicz, Katarzyna
    Miskiewicz, Piotr
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (08)
  • [3] A single-center analysis of visual outcomes and associated factors after intravenous methylprednisolone treatment for dysthyroid optic neuropathy
    Kemchoknatee, Parinee
    Tangon, Duanghathai
    Srisombut, Thansit
    BMC OPHTHALMOLOGY, 2023, 23 (01)
  • [4] Autoinimune hepatitis after high-dose intravenous methylprednisolone pulse in RR-MS
    Reuss, Reinhard
    Retzlaff, Kerstin
    Vogel, Sabine
    Franke, Folker Ernst
    Oschmann, Patrick
    CENTRAL EUROPEAN JOURNAL OF MEDICINE, 2007, 2 (03): : 356 - 359
  • [5] Evaluation of macular blood flow after intermittent intravenous infusion of high-dose corticosteroids (pulse therapy) in patients with thyroid-associated orbitopathy (TAO) using angio-OCT
    Del Noce, Chiara
    Roda, Matilde
    Desideri, Lorenzo Ferro
    Traverso, Carlo E.
    Vagge, Aldo
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 260 (02) : 571 - 576
  • [6] A single-center analysis of visual outcomes and associated factors after intravenous methylprednisolone treatment for dysthyroid optic neuropathy
    Parinee Kemchoknatee
    Duanghathai Tangon
    Thansit Srisombut
    BMC Ophthalmology, 23
  • [7] High-dose intravenous 'pulse' methylprednisolone in the treatment of severe oropharyngeal pemphigus: a pilot study
    Mignogna, MD
    Lo Muzio, L
    Ruoppo, E
    Fedele, S
    Lo Russo, L
    Bucci, E
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2002, 31 (06) : 339 - 344
  • [8] High-dose intravenous methylprednisolone in recent traumatic optic neuropathy; a randomized double-masked placebo-controlled clinical trial
    Morteza Entezari
    Zhaleh Rajavi
    Neda Sedighi
    Narssis Daftarian
    Masoumeh Sanagoo
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2007, 245 : 1267 - 1271
  • [9] High-dose intravenous methylprednisolone in recent traumatic optic neuropathy; a randomized double-masked placebo-controlled clinical trial
    Entezari, Morteza
    Rajavi, Zhaleh
    Sedighi, Neda
    Daftarian, Narssis
    Sanagoo, Masoumeh
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2007, 245 (09) : 1267 - 1271
  • [10] Successful recovery after high-dose intravenous methylprednisolone in acute hemorrhagic leukoencephalitis
    Meilof, JF
    Hijdra, A
    Vermeulen, M
    JOURNAL OF NEUROLOGY, 2001, 248 (10) : 898 - 899